Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
13.39
+0.16 (1.21%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $550.30 million as of October 23, 2024. Its market cap has increased by 105.56% in one year.
Market Cap
550.30M
Enterprise Value
298.56M
1-Year Change
105.56%
Ranking
Category
Stock Price
$13.39
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $550.30M, a decrease of -16.34%. That is a compound annual growth rate of -8.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2024 | 543.70M | 22.79% |
| Dec 29, 2023 | 442.80M | 154.04% |
| Dec 30, 2022 | 174.30M | -73.50% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Axogen | 576.80M |
| Arcturus Therapeutics Holdings | 571.94M |
| Prime Medicine | 557.61M |
| Revance Therapeutics | 554.52M |
| SI-BONE | 553.28M |
| Tectonic Therapeutic | 551.07M |
| REGENXBIO | 548.60M |
| Cartesian Therapeutics | 546.51M |